Avid Bioservices Inc (CDMO)

[exwannabe]

You have the Q1 number wrong for your Q2 estimate.

From the Q1 CC:

As a result, contract manufacturing revenue for the current quarter was $5.6 million, compared to $9.4 million for the same quarter last year. However, as this revenue shift, we now expect to recognize contract manufacturing revenue in excess of $20 million in the second quarter of fiscal year 2017.

Though I will also hope for the same as you. A nice surprise and see rev. come in over $20M.

And I think 18M is the goal SK should have put forth for Q2 (while keeping the $50-55M annual forcast). This would have been very reasonable, and given them more room to meet or beat.